Clinical trials: Survival , Tumor
Metastatic Breast Cancer
Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
The Epidemiological Strategy and Medical Economic (ESME) Breast cancer Database is a multicenter real life database using a retrospective data collection process across 18 French comprehensive cancer centers (FCCC) spread over 20…
- Trial name
- ESME-MBC (NCT03275311)
- Where
- 20 sites in France
- Volunteers
- 42,000 people
- Sponsor
- UNICANCER
Metastatic Breast Cancer
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
The goal of the study is to understand the meaning of progression-free survival for women with metastatic breast cancer and to use this understanding to create and distribute a new questionnaire to assess the effect progression…
- Trial name
- NCT01282931
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- Health Outcomes Solutions
Lymphoma; Large Cell (Diffuse) With Small Cell, Diffuse
The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma
A retrospective analysis will be performed regarding the usefulness of PET/CT performed following 2 cycle of chemotherapy in evaluation of progression, free survival and overall survival of patients with aggressive non Hodgkin…
- Trial name
- NCT00498667
- Where
- Israel
- Sponsor
- Rambam Health Care Campus
Brain Metastases
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
This research study is studying two different types of radiation as treatment for brain metastases (tumors in the brain that spread from a cancer that originated elsewhere in the body)
- Trial name
- NCT03075072
- Testing
- Whole brain radiation, Stereotactic radiation (SRS)
- Where
- 2 sites in United States
- Volunteers
- 196 people
- Sponsor
- Brigham and Women's Hospital
Colorectal Cancer, Liver Metastases
The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases
To evaluate if the addition of liver transplantation primarily utilizing liver grafts from extended criteria donors not utilized for approved indications to conventional treatment of non-resectable/ non-abatable colorectal liver…
- Conditions
- Colorectal Cancer, Liver Metastases, Colorectal Liver Metastases
- Trial name
- SOULMATE (NCT04161092)
- Testing
- Liver transplantation Ltx, Best alternative care
- Where
- 2 sites in Sweden
- Volunteers
- 45 people
- Sponsor
- Vastra Gotaland Region
Esophageal Cancer
Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer
- Trial name
- CRCRT-EC (NCT01525953)
- Testing
- Chemotherapy, Radiotherapy
- Where
- France
- Volunteers
- 110 people
- Sponsor
- Centre Oscar Lambret
Gastric Cancer
Study of Cetuximab to Treat Gastric Cancer
The purpose of this study is to evaluate the efficacy and safety of cetuximab combined with FOLFIRI in patients with advanced gastric cancer who failed first-line chemotherapy
- Trial name
- STAGE (NCT00699881)
- Testing
- cetuximab
- Where
- China
- Volunteers
- 61 people
- Sponsor
- Fudan University
Non Small Cell Lung Cancer Stage III
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
A part retrospective, part prospective cohort study to assess the difference in 2-year overall survival in patients with stage III NSCLC receiving chemoradiotherapy with curative intent in low and middle income countries before…
- Trial name
- PERTAIN (NCT02247713)
- Volunteers
- 520 people
- Sponsor
- The Netherlands Cancer Institute
Neuroendocrine Tumors
Best Therapy for Patients With Neuroendocrine Tumors
A prospective observational study containing three arms comprising different therapeutic measures to treat patients with neuroendocrine tumors in advanced stages.
- Trial name
- BESTTHERAPYNET (NCT00815620)
- Where
- Germany
- Volunteers
- 150 people
- Sponsor
- Zentralklinik Bad Berka
Pancreatic Cancer, Surgery
The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients
Pancreatic cancer is regarded as "the king of cancer". It is extremely malignant, with a low sensibility to chemotherapy and radiotherapy, and a poor prognosis. Surgical treatment is very important for pancreatic cancer.
- Trial name
- MIRROR (NCT03770559)
- Testing
- Minimal Invasive RAMPS, Open RAMPS
- Where
- China
- Volunteers
- 125 people
- Sponsor
- Peking Union Medical College Hospital
Ovarian Cancer, Breast Cancer
Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.
This is a pilot feasibility study being performed in women completing front-line treatment for breast or ovarian cancer. It is being done to evaluate whether or not an herbal combination known as Essiac (ESIAK) can improve the…
- Trial name
- NCT00287482
- Testing
- Essiac
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Women and Infants Hospital of Rhode Island
Breast Cancer Female, Survivorship
Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors
The purpose of this project was to test the efficacy of partnering with a community-led wellness program to reduce disease risk and increase wellness among breast cancer survivors.
- Trial name
- NCT03575624
- Testing
- Nutritional and goal-setting education, yoga
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Mount Mary University
Prostate Cancer
Living Well on Androgen Deprivation Therapy
Approximately half of men treated for prostate cancer will be offered hormone deprivation therapy during their cancer experience.
- Trial name
- NCT02108613
- Testing
- Exercise Sessions, Nutrition Education, Peer Support Volunteer
- Where
- Canada
- Sponsor
- British Columbia Cancer Agency
Squamous Cell Carcinoma of the Head and Neck
Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Head \& Neck squamous cell carcinomas are the commonest cancers afflicting the developing countries. Traditionally surgery or radiotherapy alone in the early stages and surgery with postoperative radiotherapy in advanced stages…
- Trial name
- NCT00652613
- Testing
- 3 Dimensional Radiation Therapy, Intensity Modulated Radiation Therapy
- Where
- India
- Volunteers
- 60 people
- Sponsor
- Tata Memorial Hospital
Liver Cancer, Pembrolizumab
The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.
Hepatocellular carcinoma (HCC) is one of the most significant cancers in our country. Since 2019, many first-line and second-line therapeutic agents for HCC have been introduced.
- Conditions
- Liver Cancer, Pembrolizumab, Atezolizumab, Lenvatinib
- Trial name
- NCT07233759
- Where
- Taiwan
- Volunteers
- 2,500 people
- Sponsor
- National Taiwan University Hospital
Breast Neoplasms, Quality of Life
Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
Cancer and its treatments can be factors that alter the quality of life of patients. The induced alteration of the quality of life can influence compliance and impact survival.
- Conditions
- Breast Neoplasms, Quality of Life, Survivorship
- Trial name
- Qualibreast-MQ (NCT04918082)
- Testing
- Quality of life questionnaires
- Where
- Martinique
- Volunteers
- 133 people
- Sponsor
- University Hospital Center of Martinique
Osteosarcoma
Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and Survival
The purpose of this work is to carry out an exhaustive analysis of the characteristics of osteosarcoma in patients with an age equal to or greater than 40 years, in the Hospital de la Santa Creu and Sant Pau in Barcelona, during…
- Trial name
- NCT03911245
- Testing
- Retrospective study. Analyze of data in medical records
- Where
- Spain
- Volunteers
- 195 people
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Anal Cancer
Anal Cancer Radiotherapy Study
This is a prospective study of patients receiving radiotherapy or chemoradiotherapy for anal cancer. Treatment effect in terms of survival and local recurrence will be analyzed.
- Trial name
- ANCARAD (NCT01937780)
- Where
- Norway
- Volunteers
- 75 people
- Sponsor
- Oslo University Hospital
Solid Tumor Malignancies, Metastatic Cancer
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
This is a hybrid decentralized, single-arm, interventional study designed to evaluate the impact of precision medicine navigation and reflexive expert review of next-generation sequencing (NGS) for patients with stage IV solid…
- Conditions
- Solid Tumor Malignancies, Metastatic Cancer, Breast Cancer, Colorectal Cancer
- Trial name
- PROGRESS (NCT06896162)
- Testing
- Expert Review, Blood or tissue samples collection., The Precision Oncology Navigation
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
To Determine the Prevalence, Penetrance of BRCA1 and BRCA2 Mutations in Romanian Womens With Breast or Ovarian Cancer
BRCA1 and BRCA2 Mutation in Romanian Population: a Study of Genotype - Phenotype Correlation at Diagnosis With Prospective Disease Outcome and Survival
Primary objective To determine BRCA1 and BRCA2 variants in 250 Romanian women with breast/ovarian cancer selected for likeliness to harbor germline mutations in these genes by specific criteria for high-risk status including age…
- Trial name
- NCT02317120
- Testing
- NGS BRCA 1 and BRCA 2 full sequencing, Multiplex ligation-dependent probe amplification (MPLA) BRCA1 BRCA2
- Where
- Romania
- Volunteers
- 250 people
- Sponsor
- Alexandru Eniu
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.